Healthcare -
Biotechnology - NASDAQ - US
$ 1.865
-2.86 %
$ 154 M
Market Cap
-0.73
P/E
EDIT - LONG-TERM DEBT
Long-term Debt EDIT - Editas Medicine, Inc.
24.4 M
LAST VALUE
23.15%
2 YEAR CAGR
-5.55%
5 YEAR CAGR
27.71%
10 YEAR CAGR